By REUTERS
The agency approved Portrazza, in combination with two forms of chemotherapy, to treat advanced squamous nonsmall cell lung cancer, the most common type.
Published: November 25, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1lgvNeL
from WordPress http://ift.tt/1NNZ3AL
via Hadi Aboukhater
No comments:
Post a Comment